Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NIRMATRELVIR\RITONAVIR Cause Product packaging issue? 57 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Product packaging issue have been filed in association with NIRMATRELVIR\RITONAVIR. This represents 0.1% of all adverse event reports for NIRMATRELVIR\RITONAVIR.

57
Reports of Product packaging issue with NIRMATRELVIR\RITONAVIR
0.1%
of all NIRMATRELVIR\RITONAVIR reports
2
Deaths
1
Hospitalizations

How Dangerous Is Product packaging issue From NIRMATRELVIR\RITONAVIR?

Of the 57 reports, 2 (3.5%) resulted in death, 1 (1.8%) required hospitalization.

Is Product packaging issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NIRMATRELVIR\RITONAVIR. However, 57 reports have been filed with the FAERS database.

What Other Side Effects Does NIRMATRELVIR\RITONAVIR Cause?

Covid-19 (22,066) Disease recurrence (20,040) Dysgeusia (7,381) Diarrhoea (3,999) Nausea (2,618) Headache (2,075) Cough (1,973) Fatigue (1,876) Incorrect dose administered (1,736) Vomiting (1,408)

What Other Drugs Cause Product packaging issue?

ACETAMINOPHEN (448) LOPERAMIDE (351) DIMETHICONE\LOPERAMIDE (348) USTEKINUMAB (221) FENTANYL (200) MINOXIDIL (173) CETIRIZINE (166) ESTRADIOL (163) GOLIMUMAB (95) CYCLOSPORINE (93)

Which NIRMATRELVIR\RITONAVIR Alternatives Have Lower Product packaging issue Risk?

NIRMATRELVIR\RITONAVIR vs NIROGACESTAT NIRMATRELVIR\RITONAVIR vs NIROGACESTAT HYDROBROMIDE NIRMATRELVIR\RITONAVIR vs NIRSEVIMAB NIRMATRELVIR\RITONAVIR vs NIRSEVIMAB-ALIP NIRMATRELVIR\RITONAVIR vs NITAZOXANIDE

Related Pages

NIRMATRELVIR\RITONAVIR Full Profile All Product packaging issue Reports All Drugs Causing Product packaging issue NIRMATRELVIR\RITONAVIR Demographics